相似文献
1
Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.
Cell Death Dis. 2024 Jan 29;15(1):92. doi: 10.1038/s41419-023-06363-1.
2
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.
Cell Death Dis. 2023 May 4;14(5):304. doi: 10.1038/s41419-023-05836-7.
3
Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance.
Commun Biol. 2021 Jan 4;4(1):22. doi: 10.1038/s42003-020-01549-1.
4
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer.
Clin Cancer Res. 2019 Nov 15;25(22):6839-6851. doi: 10.1158/1078-0432.CCR-19-0317. Epub 2019 Aug 22.
5
Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer.
J Biol Chem. 2007 Feb 9;282(6):3571-83. doi: 10.1074/jbc.M608487200. Epub 2006 Dec 4.
6
The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer.
Nat Commun. 2023 Nov 28;14(1):7794. doi: 10.1038/s41467-023-43676-3.
7
Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer.
Redox Biol. 2023 Jun;62:102686. doi: 10.1016/j.redox.2023.102686. Epub 2023 Mar 21.
8
miR-145-5p Inhibits Neuroendocrine Differentiation and Tumor Growth by Regulating the SOX11/MYCN Axis in Prostate cancer.
Front Genet. 2022 Mar 9;13:790621. doi: 10.3389/fgene.2022.790621. eCollection 2022.
9
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
Neoplasia. 2013 Jan;15(1):1-10. doi: 10.1593/neo.121550.
10
Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens.
Oncotarget. 2016 Mar 29;7(13):16112-29. doi: 10.18632/oncotarget.7448.
引用本文的文献
1
The Effects of Cancer Immunotherapy on Fertility: Focus on Hematological Malignancies.
Biomedicines. 2024 Sep 15;12(9):2106. doi: 10.3390/biomedicines12092106.
Zotero 插件